Circulating Tumor Cells and the CellSearch Assay

Metastatic Prostate Cancer (MPC)

April 2011

Now let's discuss the use of the CellSearch Assay for metastatic prostate cancer.

In the United States in 2010, there were approximately 217,000 new cases of prostate cancer with 32,000 deaths. Of the new cases, nearly 4% had evidence of metastatic disease at diagnosis.

< Previous Slide

Metastatic Prostate Cancer (MPC)

Next Slide >

 

Jump to section:

• Introduction
• Circulating Tumor Cell (CTC)
• The Metastatic Process
• Needle in a Haystack...
• Circulating Tumor Cells
• The CellSearch System (Veridex LLC)
• Automated Sample Preparation
• Labeling and Identification of CTCs
• Labeling and Identification of Cells
• Cell Analysis
• Mayo Medical Laboratories FDA-Cleared Assays
• Metastatic Breast Cancer (MBC)
• CellSearch Use in MBC Clinical Trial⁶
• Progression-Free Survival in MBC
• Overall Survival in MBC
• Metastatic Colorectal Cancer (MCRC)
• CellSearch Use in MCRC Clinical Trial⁸
• Progression-Free Survival in MCRC
• Overall Survival in MCRC
• Metastatic Prostate Cancer (MPC)
• CellSearch Use in MPC Clinical Trial⁸
• Progression-Free Survival in MPC
• Overall Survival in MPC
• The Future of CTC
• References
• Questions?